We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock
NURO

Delisted

NURO was delisted on the 1st of May, 2025.

Back to rankings

11 hedge funds and large institutions have $967K invested in NeuroMetrix, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more capital invested

Capital invested by funds: $253K → $967K (+$714K)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

22% more funds holding

Funds holding: 9 → 11 (+2)

5.34% more ownership

Funds ownership: 2.12% → 7.46% (+5.3%)

Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$370K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$191K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$167K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$90.3K
5
Squarepoint
Squarepoint
New York
+$81.6K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$127K
2
TRCT
Tower Research Capital (TRC)
New York
-$21K
3
UBS Group
UBS Group
Switzerland
-$6.58K

NURO Hedge Fund Activity: Q1 2021 in Review

11 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q1 2021, worth a combined $967K — up 282% from $253K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NURO positions and 4 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $370K. The largest seller was Virtu Financial, exiting entirely with an estimated $127K sold.

  • 11 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q1 2021, up from 9 in Q4 2020.
  • Funds reported $967K of NeuroMetrix, Inc. Common Stock stock for Q1 2021, up 282% quarter-over-quarter.
  • 6 funds opened new NeuroMetrix, Inc. Common Stock positions in Q1 2021 and 4 closed out, a net change of +2 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q1 2021 was Renaissance Technologies, an estimated $370K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q1 2021 was Virtu Financial, an estimated $127K sold.

Based on aggregated 13F filings for Q1 2021.